GLP-1 Analogs Showing Broad Neuroprotective Potential Across Neurological Disorders: Paul Edison, MBBS, PhD, FRCPI

The professor of neuroscience at the Imperial College London discussed the emerging role of GLP-1 analogs as neuroprotective agents with potential benefits in neurodegenerative conditions. [WATCH TIME: 4 minutes]:

Source: Neurology Read More

Previous PostVideo: Advancing Parkinson’s Disease Care While Maintaining Focus on Dyskinesia
Next PostDenali Announces Rolling Regulatory Submission of Tividenofusp Alfa for Hunter Syndrome

GLP-1 Analogs Showing Broad Neuroprotective Potential Across Neurological Disorders: Paul Edison, MBBS, PhD, FRCPI

Previous PostVideo: Advancing Parkinson’s Disease Care While Maintaining Focus on Dyskinesia

Next PostDenali Announces Rolling Regulatory Submission of Tividenofusp Alfa for Hunter Syndrome

Related Posts

<![CDATA[Weighing Disease-Modifying Therapy Discontinuation in Older, Stable Patients With MS]]>

<![CDATA[The Future of Alzheimer Disease Care: Toward Biomarker-Guided Personalized Treatment]]>

<![CDATA[FDA AdComm Votes Against Recommending Deramiocel Approval, Tazbentetol Shows Durable Cognitive Benefit in AD, Salanersen’s FDA Breakthrough Designation Meaning]]>

Categories